ARCHIVES

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

This article is from The Cancer Letter archive.

Vol. 38 No. 15 | April 13, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

May 5, 1995